ANTX vs. DERM, CARM, ANEB, LABP, ASMB, CUE, VTVT, VHAQ, CRVS, and RLYB
Should you be buying (ANTX) stock or one of its competitors? The main competitors of (ANTX) include Journey Medical (DERM), Carisma Therapeutics (CARM), Anebulo Pharmaceuticals (ANEB), Landos Biopharma (LABP), Assembly Biosciences (ASMB), Cue Biopharma (CUE), vTv Therapeutics (VTVT), Viveon Health Acquisition (VHAQ), Corvus Pharmaceuticals (CRVS), and Rallybio (RLYB). These companies are all part of the "pharmaceutical preparations" industry.
Journey Medical (NASDAQ:DERM) and (ANTX) (NYSE:ANTX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership.
Journey Medical presently has a consensus price target of $8.50, suggesting a potential upside of 155.26%. (ANTX) has a consensus price target of $6.67, suggesting a potential upside of 181.29%. Given Journey Medical's higher possible upside, analysts clearly believe (ANTX) is more favorable than Journey Medical.
Journey Medical has a beta of 0.8, suggesting that its share price is 20% less volatile than the S&P 500. Comparatively, (ANTX) has a beta of -0.24, suggesting that its share price is 124% less volatile than the S&P 500.
In the previous week, Journey Medical had 5 more articles in the media than (ANTX). MarketBeat recorded 5 mentions for Journey Medical and 0 mentions for (ANTX). (ANTX)'s average media sentiment score of 0.32 beat Journey Medical's score of 0.00 indicating that Journey Medical is being referred to more favorably in the media.
Journey Medical has higher revenue and earnings than (ANTX). Journey Medical is trading at a lower price-to-earnings ratio than (ANTX), indicating that it is currently the more affordable of the two stocks.
(ANTX) has a net margin of 0.00% compared to (ANTX)'s net margin of -4.87%. (ANTX)'s return on equity of -34.08% beat Journey Medical's return on equity.
7.3% of Journey Medical shares are held by institutional investors. Comparatively, 90.5% of (ANTX) shares are held by institutional investors. 19.4% of Journey Medical shares are held by insiders. Comparatively, 18.5% of (ANTX) shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
(ANTX) received 90 more outperform votes than Journey Medical when rated by MarketBeat users. However, 100.00% of users gave Journey Medical an outperform vote while only 59.48% of users gave (ANTX) an outperform vote.
Summary
Journey Medical beats (ANTX) on 11 of the 16 factors compared between the two stocks.
Get (ANTX) News Delivered to You Automatically
Sign up to receive the latest news and ratings for ANTX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ANTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
